Via this mechanism, platelet aggregation is inhibited in response to various stimuli such as platelet activating factor PAF , collagen and adenosine diphosphate ADP. Dipyridamole inhibits phosphodiesterase PDE in various tissues. Hemodynamics In dogs intraduodenal doses of dipyridamole of 0.
Onset of action was in about 24 minutes and effects persisted for about 3 hours. Similar effects were observed following IV Persantine dipyridamole in doses ranging from 0. In man the same qualitative hemodynamic effects have been observed. However, acute intravenous administration of Persantine dipyridamole may worsen regional myocardial perfusion distal to partial occlusion of coronary arteries. Pharmacokinetics and Metabolism Following an oral dose of Persantine dipyridamole tablets, the average time to peak concentration is about 75 minutes.
The decline in plasma concentration following a dose of Persantine dipyridamole tablets fits a two-compartment model. The alpha half-life the initial decline following peak concentration is approximately 40 minutes. The beta half-life the terminal decline in plasma concentration is approximately 10 hours. Dipyridamole is highly bound to plasma proteins. It is metabolized in the liver where it is conjugated as a glucuronide and excreted with the bile.
Do not miss any scheduled visits to your doctor. Store dipyridamole at room temperature away from moisture and heat. What happens if I miss a dose Persantine? Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at your next regularly scheduled time. Do not take extra medicine to make up the missed dose. What happens if I overdose Persantine?
Seek emergency medical attention if you think you have used too much of this medicine. Overdose symptoms may include sweating, warmth or tingly feeling under your skin, dizziness, weakness, restlessness, fast heart rate, feeling light-headed, or fainting.
What should I avoid while taking dipyridamole Persantine? Hemodynamics In dogs intraduodenal doses of Dipyridamole of 0. Onset of action was in about 24 minutes and effects persisted for about 3 hours. Similar effects were observed following IV Dipyridamole in doses ranging from 0. In man the same qualitative hemodynamic effects have been observed. However, acute intravenous administration of Dipyridamole may worsen regional myocardial perfusion distal to partial occlusion of coronary arteries.
Pharmacokinetics and Metabolism Following an oral dose of Dipyridamole tablets, the average time to peak concentration is about 75 minutes. The decline in plasma concentration following a dose of Dipyridamole tablets fits a two-compartment model.
The alpha half-life the initial decline following peak concentration is approximately 40 minutes. The beta half-life the terminal decline in plasma concentration is approximately 10 hours. Dipyridamole is highly bound to plasma proteins.
It is metabolized in the liver where it is conjugated as a glucuronide and excreted with the bile. Indications and Usage for Dipyridamole Dipyridamole tablets are indicated as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement.
Contraindications Hypersensitivity to Dipyridamole and any of the other components. Precautions General Coronary Artery Disease Dipyridamole has a vasodilatory effect and should be used with caution in patients with severe coronary artery disease e.
Chest pain may be aggravated in patients with underlying coronary artery disease who are receiving Dipyridamole.
© Copyright 2017 Dipyridamole 75mg *** www.get-club.net.